Published on
May 13, 2026
- 09:00 GMT
Violet Therapeutics Raises $4.75M Seed Extension to Advance Novel Therapeutic for Synaptic Preservation and Repair
CAMBRIDGE, MA, UNITED STATES, May 13, 2026 /EINPresswire.com/ -- Violet Therapeutics (“Violet”), a biotechnology company developing first-in-class therapies for neurodegenerative diseases, today announced the closing of a $4.75M seed extension financing …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
